期刊文献+

医用纳米级Fe_3O_4磁流体的急性毒理学实验研究 被引量:14

Experimental Study on Acute Toxicology of Fe_3O_4 Nano-Magnetic Ferrofluid
下载PDF
导出
摘要 目的 检测医用纳米级Fe3 O4磁流体的急性毒性 ,为进一步研究其长期毒性以及载附药物的临床试验打下基础。方法 按不同浓度不同容积分别通过口服法、静脉注射法及腹腔注射法给予小鼠医用纳米级Fe3 O4磁流体 ,观察小鼠的急性毒性反应和主要脏器的病理学改变。结果 小鼠口服半数致死剂量LD50 >2 10 4 8mg/kg ,最大无毒性剂量ED0 为 32 0 10mg/kg ;静脉注射LD50 >4 38 5 0mg/kg ,ED0 为 16 0 0 5mg/kg ;腹腔注射LD50 >15 78 6mg/kg ,ED0 为 32 0 10mg/kg。主要脏器未见明显病理改变。 结论 医用纳米级Fe3 O4磁流体在动物体内的急性毒性很低 ,可以考虑作为药物载体。 Objective To investigate the acute toxicology of Fe 3O 4 nano-magnetic ferrofluid for further use. Methods The acute toxic reaction and the main viscera pathological morphology of mice were evaluated after given Fe 3O 4 nano-magnetic ferrofluid by oral administration, intravenous and intraperitoneal injection with different doses respectively. Results LD 50 (median lethal dose) was >2104.8 mg/kg, ED 0 (maximum non-effect dose) 320.10 mg/kg by oral administration, and degeneration and necrosis of viscera were not found; LD 50 was >438.50 mg/kg, ED 0 160.05 mg/kg by intravenous injection, and degeneration and necrosis were not found either; And LD 50 was >1578.6 mg/kg, ED 0 320.10 mg/kg by intraperitoneal injection. Conclusion Fe 3O 4 nano-magnetic ferrofluid, of which toxicity is very low, may be used as drug carrier.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2004年第4期452-454,458,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家 8 6 3重点资助项目 (No 2 0 0 1AA2 180 5 1)
关键词 纳米级 FE3O4 磁流体 急性毒理学 药物载体 Fe 3O4 nano-magnetic ferrofluid acute toxicity drug carrier
  • 相关文献

参考文献12

  • 1Lubbe A S, Bergemann C, Riess H et al. Clinical experiences with magnetic drug targeting: a phase Ⅰ study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res, 1996, 56:4686
  • 2Susan E M, Colin W P, Michael D T. Macromolecular systems for chemotherapy and magnetic resonance imaging. Adv Drug Deliv Rev, 1996, 18:219
  • 3Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug DelivRev, 2003, 55:329
  • 4Goodwin S C, Bittner C A, Peterson C L et al. Singledose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci, 2001, 60:177
  • 5Jordan A, Scholz R, Wust P et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinomainvivo. Int J Hyperthermia, 1997, 13:587
  • 6Guidance for industry. single dose acute toxicity testing for pharmaceuticals. CEDR, 1996. 1~2
  • 7Toxicokinetics: the assessment of systemic exposure in toxicity studies. CEDR, 1995. 9~10
  • 8WHO food additives series 6: toxicological evaluation of some food colours, enzymes, flavours enhancers, thickening agents and certain food additives. WHO, 1974.
  • 9Hafeli U O, Gayle J P. In vitro and in vivo toxicity of magnetic microspheres. JMMM, 1999, 194:76
  • 10Wagner S, Schnorr J, Pilgrimm H et al. Monomer coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol, 2002,37: 167

同被引文献134

引证文献14

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部